An open-label study to evaluate the utility of the apoptosis imaging biomarker [18F]ML-10 to assess the response to chemotherapy in patients with non Hodgkin's lymphoma.

Registry ID

EUCTR2010-019832-11

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

GlaxoSmithKline Research and Development Ltd

Start date

2010-06-04

Completion date

2012-02-06

Last update

2026-08-16

Conditions

• Non Hodgkin’s lymphoma

Summary

We plan to assess the amount of [18F]ML-10 that is taken up by cancer cells undergoing programmed cell death or apoptosis. We will assess this after chemotherapy treatment in patients with Non Hodgkin's lymphoma, using positron emission tomography (PET) scanning.

Locations

• , , UK

View on source registry